Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
CMVLF:OTCMKTS
Cellectis SA
$3.08
0.00%
(0.00) 1D
Mar 30, 3:40:10 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CMVLF...
Mkt. cap
280.36M
Avg. vol.
10.00
Volume
0.00
52-wk high
$5.04
52-wk low
$1.25
Beta
3.15
Shares outstanding
72.09M
No. of employees
227
News stories
From sources across the web
Profile
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina. Wikipedia
About Cellectis SA
CEOAndré Choulika
Employees227
Founded1999
Headquarters-
SectorBiotechnology
Websitecellectis.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
12.03M
18.19M
37.16M
12.21M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
21.93M
23.08M
24.07M
24.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.70M
5.08M
5.21M
4.80M
Operating expense
26.21M
27.78M
29.12M
29.56M
Total operating expenses
26.21M
27.78M
29.12M
29.56M
Operating income
-14.18M
-9.59M
8.04M
-17.35M
Other non operating income
2.87M
-282.00K
-7.06M
-8.80M
EBT including unusual items
-18.13M
-23.74M
589.00K
-26.74M
EBT excluding unusual items
-18.13M
-23.74M
589.00K
-26.74M
Income tax expense
-
-
-
-423.00K
Effective tax rate
-
-
-
1.58%
Other operating expenses
-426.00K
-378.00K
-154.00K
320.00K
Net income
-18.13M
-23.74M
589.00K
-26.32M
Net profit margin
-150.71%
-130.46%
1.58%
-215.60%
Earnings per share
-0.17
-0.22
0.02
-0.24
Interest and investment income
-
2.20M
2.31M
2.08M
Interest expense
-
-2.06M
-2.11M
-2.03M
Net interest expenses
-
139.00K
206.00K
44.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.13M
-6.46M
11.16M
-15.33M
Gain or loss from assets sale
1.00K
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer